These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14066384)

  • 1. POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. II. CLINICAL REACTION AND ANTIBODY RESPONSE.
    STONE S; HU R; KRUGMAN S; TYTELL AA; HILLEMAN MR
    J Allergy; 1963; 34():420-5. PubMed ID: 14066384
    [No Abstract]   [Full Text] [Related]  

  • 2. POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA.
    HILLEMAN MR; HAMPIL B; SWEET BH
    J Allergy; 1963; 34():413-9. PubMed ID: 14066383
    [No Abstract]   [Full Text] [Related]  

  • 3. REACTIONS TO OIL-ADJUVANT TRACHOMA VACCINE: TAIWAN 1962-1964.
    NEAVE C; WOOLRIDGE RL
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1965 Jan; 64():1-6. PubMed ID: 14281349
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of poliomyelitis virus vaccine in light mineral oil adjuvant in a community immunization program and report of reactions encountered.
    CUTLER JC; LESESNE L; VAUGHN I
    J Allergy; 1962; 33():193-209. PubMed ID: 13882815
    [No Abstract]   [Full Text] [Related]  

  • 5. THE RESPONSE OF PREMATURE INFANTS TO INFECTION WITH TYPE 3 ATTENUATED POLIOVIRUS.
    PAGANO JS; PLOTKIN SA; CORNELY D
    J Pediatr; 1964 Aug; 65():165-75. PubMed ID: 14198406
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of oral poliovirus vaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type I vaccine at birth.
    SABIN AB; MICHAELS RH; ZIRING P; KRUGMAN S; WARREN J
    Pediatrics; 1963 Apr; 31():641-50. PubMed ID: 13975877
    [No Abstract]   [Full Text] [Related]  

  • 7. [IMMUNOLOGIC RESPONSE TO THE ORAL ADMINISTRATION OF TRIVALENT VACCINE (SABIN)].
    VILLALOBOSRODAS A; DELPILAROLMOS M
    Salud Publica Mex; 1963; 5():933-6. PubMed ID: 14119839
    [No Abstract]   [Full Text] [Related]  

  • 8. [PECULIARITIES IN VIRUS EXCRETION AND ANTIBODY FORMATION AFTER ADMINISTRATION OF A "BALANCED" LIVE VACCINE MIXTURE OF POLIOVIRUS TYPES I AND II].
    HENIGST W; MUELLER F; WUERSCHING F
    Z Hyg Infektionskr; 1963 Dec; 149():383-400. PubMed ID: 14123271
    [No Abstract]   [Full Text] [Related]  

  • 9. A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON.
    HOWELL RW; STOTT AN
    Br J Ind Med; 1964 Oct; 21(4):259-64. PubMed ID: 14249893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applied immunology of mineral oil adjuvants.
    DAVENPORT FM
    J Allergy; 1961; 32():177-89. PubMed ID: 13719954
    [No Abstract]   [Full Text] [Related]  

  • 11. IMMUNOLOGIC RESPONSE TO ORAL POLIOMYELITIS VACCINE.
    ANDELMAN SL
    IMJ Ill Med J; 1963 Aug; 124():131-3. PubMed ID: 14046358
    [No Abstract]   [Full Text] [Related]  

  • 12. [ANTIBODY RESPONSE TO CONCENTRATED AND PURIFIED ANTI-POLIOMYELITIS VACCINE].
    BRANCATO P; PICCIOTTO L
    Riv Ist Sieroter Ital; 1963; 38():186-93. PubMed ID: 14084460
    [No Abstract]   [Full Text] [Related]  

  • 13. [FIELD TRIAL WITH LIVE ORAL POLIOVIRUS VACCINE. II. PRODUCTION OF NEUTRALIZING ANTIBODIES FOLLOWING THE ADMINISTRATION OF MONOVALENT ORAL POLIOVIRUS VACCINE].
    OGAWA M; KANNO T; URASAWA S
    Sapporo Igaku Zasshi; 1963 Mar; 23():202-9. PubMed ID: 14057343
    [No Abstract]   [Full Text] [Related]  

  • 14. FIELD TRIALS OF ADJUVANT AND SALINE INFLUENZA VACCINES.
    HERBERT WJ; SELWYN S; PHILP JR
    Br J Prev Soc Med; 1965 Apr; 19(2):97-100. PubMed ID: 14319217
    [No Abstract]   [Full Text] [Related]  

  • 15. COMPARATIVE SEROLOGICAL STUDIES ON THE EFFECTIVENESS OF MONOVALENT LIVE POLIOVIRUS VACCINES GIVEN ALTERNATIVELY IN THE ORDER 2-3-1 AND 1-3-2.
    FORNOSI F; TALOS I
    Acta Microbiol Acad Sci Hung; 1964-1965; 11():263-9. PubMed ID: 14267556
    [No Abstract]   [Full Text] [Related]  

  • 16. [EXPERIENCES WITH A NEW ATTENUATED POLIOVIRUS TYPE 3 USOL-D BAC DEVELOPED IN CZECHOSLOVAKIA].
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H; ADAMOVA V; STAREK M
    Cesk Epidemiol Mikrobiol Imunol; 1964 Nov; 13():358-69. PubMed ID: 14241623
    [No Abstract]   [Full Text] [Related]  

  • 17. [EXPERIMENTAL STUDIES ON LIVER DAMAGE INDUCED BY ADJUVANT].
    TAKEDA K
    Arerugi; 1965 Feb; 14():54-9. PubMed ID: 14329546
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant influenza vaccines.
    Stuart-Harris CH
    Bull World Health Organ; 1969; 41(3):617-21. PubMed ID: 5309486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT.
    HILLEMAN MR
    Am Rev Respir Dis; 1964 Nov; 90():683-706. PubMed ID: 14211456
    [No Abstract]   [Full Text] [Related]  

  • 20. [ANTIBODY FORMATION AFTER 3 DOSES OF QUADRUPLE VACCINE INJECTION FOLLOWED BY TRIVALENT ORAL POLIOMYELITIS VACCINE].
    HENIGST W; MUELLER F
    Dtsch Med Wochenschr; 1965 Aug; 90():1502-6. PubMed ID: 14344415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.